Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . TONG REN TANG BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED 北京 同仁堂 國藥 有限公司 ( Incorporated in Hong Kong with limited liability ) ( Stock Code : 3613 ) 2021 INTERIM RESULTS ANNOUNCEMENT The board of directors ( the " Board " ) of Beijing Tong Ren Tang Chinese Medicine Company Limited ( the " Company " ) is pleased to announce the unaudited results of the Company and its subsidiaries for the six months ended 30 June 2021. This announcement , containing the full text of the 2021 interim report of the Company , complies with the relevant requirements of the Rules ( the “ Listing Rules ” ) Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited ( the " Stock Exchange " ) in relation to information to accompany preliminary announcement of interim results . Printed version of the Company's 2021 interim report will be delivered to the shareholders of the Company and available for viewing on the websites of the Stock Exchange at www.hkexnews.hk and of the Company at cm.tongrentang.com on or before 30 September 2021 . By order of the Board Beijing Tong Ren Tang Chinese Medicine Company Limited Ding Yong Ling Chairman Hong Kong , 6 August 2021 As at the date of this announcement , the composition of the Board is as follows : Executive Directors : Ms. Ding Yong Ling ( Chairman ) Mr. Chen Fei Ms. Lin Man Independent Non - executive Directors : Mr. Tsang Yok Sing , Jasper Mr. Zhao Zhong Zhen Mr. Chan Ngai Chi